HF10 induced a cytotoxic immune response against recurrent breast cancer [76], and in a pancreatic ductal carcinoma trial HSV+ tumor cells were present at autopsy, as well as significant increases in CD8+ T cells and macrophages compared to control specimens [77]. Here, CD8A is linked to breast cancer.